TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...
A San Diego startup may have created what the scientific community has talked about for decades – a kind of universal flu ...
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a stock dividend of one share of common stock for every 1,000 shares of outstanding common stock as well as one share ...
PONTE VEDRA, FL / ACCESS Newswire / December 30, 2025 / Some companies enter a market because they see opportunity. Others ...
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
Intense workouts, supplements, the 5am club — don’t follow social media’s wellness hacks blindly, says life coach ...
Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...
PONTE VEDRA, FL / / December 29, 2025 / Every industry has its forgotten corners. In anticoagulation, those corners turned ...
After two years, people who undergo metabolic and bariatric surgery achieve weight loss that is about five times greater than ...
See why TG Therapeutics, Inc. earns a Buy rating, with insights on Briumvi's efficacy and market growth in multiple sclerosis ...
6d
Cadrenal Therapeutics: Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On
PONTE VEDRA, FL / ACCESS Newswire / December 29, 2025 / Every industry has its forgotten corners. In anticoagulation, those corners turned into entire neighborhoods. For years, the field centered itse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback